Retour
76
Fourchette du Jour
63,54 €
67,31 €
Fourchette 52 Semaines
38,51 €
85,25 €
Volume
808 345
Moyenne 50J / 200J
69,58 €
/
62,35 €
Clôture Précédente
64,51 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -41,1 | 0,4 |
| P/B | 8,0 | 2,9 |
| ROE % | -23,4 | 3,8 |
| Net Margin % | -14,7 | 3,9 |
| Rev Growth 5Y % | 67,7 | 10,0 |
| D/E | 0,3 | 0,2 |
Objectif de Cours des Analystes
Hold
89,00 €
+38.8%
Low: 68,00 €
High: 100,00 €
BPA Prévisionnel
-0,63 €
CA Est.
690 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
9,19 €
8,89 € – 9,67 €
|
1,3 B | 2 |
| FY2029 |
6,99 €
6,76 € – 7,35 €
|
1,2 B | 2 |
| FY2028 |
5,08 €
3,10 € – 6,73 €
|
1,1 B | 4 |
Points Clés
Revenue grew 67,73% annually over 5 years — strong growth
Debt/Equity of 0,27 — conservative balance sheet
Negative free cash flow of -22,31M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 78,98%
Capital efficient — spends only 2,18% of revenue on capex
Croissance
Revenue Growth (5Y)
67,73%
Revenue (1Y)146,71%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-23,39%
ROIC-12,18%
Net Margin-14,72%
Op. Margin-15,72%
Sécurité
Debt / Equity
0,27
Current Ratio3,85
Interest Coverage-7,94
Valorisation
P/E Ratio
-41,09
P/B Ratio7,95
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 146,71% | Revenue Growth (3Y) | 408,63% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 67,73% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 451,36M | Net Income (TTM) | -66,42M |
| ROE | -23,39% | ROA | -11,81% |
| Gross Margin | 93,20% | Operating Margin | -15,72% |
| Net Margin | -14,72% | Free Cash Flow (TTM) | -22,31M |
| ROIC | -12,18% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,27 | Current Ratio | 3,85 |
| Interest Coverage | -7,94 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -41,09 | P/B Ratio | 7,95 |
| P/S Ratio | 6,05 | PEG Ratio | 1,07 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 2,73B | Enterprise Value | 2,64B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 451,36M | 182,95M | 17,45M | 25,82M | 57,03M |
| Net Income | -66,42M | -115,55M | -135,89M | -62,09M | -13,83M |
| EPS (Diluted) | -1,59 | -3,07 | -4,62 | -2,52 | -0,67 |
| Gross Profit | 420,68M | 170,13M | 15,85M | 24,86M | 54,95M |
| Operating Income | -70,97M | -120,57M | -143,16M | -62,71M | -12,16M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 562,16M | 376,99M | 265,49M | 227,86M | 178,91M |
| Total Liabilities | 218,73M | 152,46M | 68,50M | 34,96M | 12,18M |
| Shareholders' Equity | 343,43M | 224,53M | 196,99M | 192,90M | 166,73M |
| Total Debt | 93,64M | 72,45M | 30,22M | 20,21M | 1,89M |
| Cash & Equivalents | 183,64M | 94,82M | 224,95M | 71,66M | 171,33M |
| Current Assets | 522,78M | 356,71M | 256,13M | 225,38M | 175,95M |
| Current Liabilities | 135,70M | 80,61M | 36,94M | 15,43M | 11,48M |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Full Throttle
#7 of 146
Activité Récente
Entré
Full Throttle
Mar 24, 2026